1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Optimum Therapeutics, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer Docetaxel, Suramin - Carcinoma, Non Small Cell Lung | Phase 2 | Completed | University of Wisconsin, Madison | 80 | 2012-06-01 | 2020-05-12 |
| Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer Suramin Drug:Docetaxel Drug: Carboplatin, Placebo Drug: Docetaxel Drug: Carboplatin - Non-small Cell Lung Cancer | Phase 2 | Terminated | Optimum Therapeutics, LLC | 14 | 2010-08-01 | 2015-05-21 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (1)
Docetaxel (2) · Suramin (2) · Carboplatin (1)
United States (2)
Anne M Traynor, MD (1) · Rafael Santana-Davila, MD (1)